Time for evidence-based cytology

CytoJournal

Volumn 4, Issue , 2007, Pages

  Dey, Pranab ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; CANCER DIAGNOSIS; CELL COUNT; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; GYNECOLOGIC DISEASE; HUMAN; MEDICAL RESEARCH; PRACTICE GUIDELINE; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; TRACHEOBRONCHIAL TOILET; URINALYSIS; UTERINE CERVIX CYTOLOGY;

EID: 33846537946     PISSN: None     EISSN: 17426413     Source Type: Journal    
DOI: 10.1186/1742-6413-4-1     Document Type: Review

References (75)

1. Evidence based medicine: what it is and what it is not. DL Sackett WMC Rosenberg JAM Gray RB Haynes WS Richardson, BMJ 1996 312 71 72 8555924
2. Review of the state of the art and recommendations of the Papanicolaou society of cytopathology for urinary cytology procedures and reporting. The Papanicolaou society of cytopathology practice guidelines task force. LJ Layfield TM Elsheikh A Fili R Nayar V Shidham, Diagn Cytopathol 2003 30 24 30 10.1002/dc.10401
3. Papanicolaou society of cytopathology task force on standards of practice. Guidelines of the Papanicolaou society of cytopathology for the examination of cytologic specimens obtained from the respiratory tract. Diagn Cytopathol 1999 21 61 69 10.1002/(SICI)1097-0339(199907)21:1<61::AID-DC173.0. CO;2-O 10405813
4. The Papanicolaou society of cytopathology task force on standards of practice. Guidelines of the Papanicolaou society of cytopathology for the examination of fine needle aspiration specimens from thyroid nodules. Diagn Cytopathol 1996 15 84 89 10.1002/(SICI)1097-0339(199607)15:1<84::AID-DC183.0. CO;2-8 8807260
5. The uniform approach to breast fine needle aspiration biopsy. M Bibbo A Abati, Acta Cytol 1996 40 1119 1126
6. Potential benefits, limitations, and harms of clinical guidelines. SH Woof R Grol A Hutchinson M Eccles J Grimshaw, BMJ 1999 318 527 530 10024268
7. Are laboratory investigations recommended in current medical practice guidelines supported by available evidences? J Watine, Clin Chem Lab Med 2002 40 252 255 10.1515/CCLM.2002.041 12005215
8. Grading system for recommendations in evidence based clinical guidelines. Scottish Intercollegiate Guidelines Network (SIGN), Report of a review of the system for grading recommendations in SIGN guidelines Edinburgh: Scottish Intercollegiate Guidelines Network 2000 http://www.sign.ac.uk/
9. Mapping the evidence base of pathology. A Booth, J Pathol 1999 188 344 350 10.1002/(SICI)1096-9896(199908)188:4<344::AID-PATH3313.0.CO;2-C 10440743
10. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. D Solmon D Davey R Kurman A Moriarty D O'Connor M Prey S Rabb M Sherman D Wilbur T Wright T Young, JAMA 2002 287 2114 2119 10.1001/jama.287.16. 2114 11966386
11. http://www.cytopathology.org/website/article.asp?id=384
12. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum. Sensitivity and specificity of an alteration to routine cytology. A Bocking S Biesterfeld R Chatelain G Gien-Gerlach E Esser, Acta Cytol 1992 36 37 47 1546511
13. Fine needle aspiration biopsy versus sputum and bronchial material in the diagnosis of lung cancer: a comparative study of 168 patients. WW Johnston, Acta Cytol 1998 32 641 648
14. Cytopathologic diagnosis of lung cancer. YS Erozan JK Frost, Semin Oncol 1974 1 191 198 4620432
15. st, 1952 until December 31st, 1960. LG Koss MR Melamed JT Goodner, Acta Cytolo 1964 8 104 113
16. Ten years of respiratory cytopathology of Duke University Medical Center III. The cytopathologic diagnosis of lung cancer during the year 1970 to 1974 noting the significance of specimen number and type. WW Johnston, Acta Cytol 1981 25 103 107 6941610
17. Recent advances in pulmonary cytopathology. SD Greenberg, Hum Pathol 1993 14 901 912 10.1016/S0046-8177(83)80165-8
18. Efficacy of cervical smear collection devices: a systematic review and meta-analysis. P Martin-Hirsch R Lilford G Jarvis HC Kitchener, Lancet 1999 354 1763 1770 10.1016/S0140-6736(99)02353-3 10577637
19. http://www.cancerscreening.nhs.uk/cervical/index.html
20. Cell preparation methods and criteria for sample adequacy. IAC Task force summary. IAC TASK FORCE NO 21. E Mc Googan TJ Colgan I Ramzy, Acta Cytol 1998 42 25 32 9479321
21. Bethesda 2001. JHF Smith, Cytopathology 2002 13 4 10 10.1046/j.1365-2303. 2002.00397.x 11985563
22. http://www.bethesda2001.cancer.gov/postwrkshp_recs.html
23. The influence of sample takers on the cellular composition of cervical smears. GP Vooijs A Elias Y van der Graaf, Acta Cytol 1986 30 251 257 3459325
24. Comparison of transformation zone sampling rates a potentially useful indicator of smear taker performance. W Young, Cytopathology 2000 11 116 223 10.1046/j.1365-2303.2000.00230.x 10772011
25. Papanicolaou smears without endocervical cells: are they inadequate? C Kivlahan E Ingram, Acta Cytol 1986 30 258 260 3459326
26. Should we report cervical smears lacking endocervical component as unsatisfactory? MK Sidawy SO Tabbara SG Silverberg, Diagn Cytopathol 1992 8 567 570 1468332
27. Longitudinal analysis of histologic high grade disease after negative cervical cytology according to endocervical status. H Mitchell, Cancer (Cancer Cytopathol) 2001 93 237 240
28. Papanicolaou smear adequacy: effect of different techniques in specific fertility states. JE Humblin CD Brock L Litchfield, J Fam Pract 1985 20 257 260 3973541
29. Endocervical cell recovery. D Lee JB Wheelock GA Patrissi, Mil Med 1992 157 1 4 1603368
30. Intraobserver and interobserver variability in the quality assessment of cervical smears. PJJ Klinkhamer GP Vooijs AFJ de Haan, Acta Cytol 1989 33 215 218 2929223
31. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. D Stockton P Cooper RN Lonsdale, J Med Screen 1997 4 40 43 9200062
32. Performance of ThinPrep smear method in a Gynaecology outpatient setting in Kuwait. UK Luthra M Chishti P Dey SV Jolly M Abdulla DK Das, Acta Cytol 2002 46 303 310 11917577
33. Fine needle aspiration cytology of the thyroid, 1980 to 1986. JR Goellner H Gharib CS Grant DA Johnson, Acta Cytol 1987 31 587 590 3673463
34. Fine needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and management of solitary thyroid nodules. GK Nguyen J Ginsberg PM Crockford, Pathol Annu 1991 26 63 91 2014145
35. Semiquantitative criteria for fine needle aspiration biopsy diagnosis: Reduced false-negative diagnosis. JI Hamburger M Husain, Diag Cytopathol 1988 4 14 7
36. What constitutes an adequate smear in needle aspiration cytology of the breast? LJ Layfield EE Mooney B Glaskow S Hinchowitz A Coogan, Cancer Cytopathol 1997 81 16 21
37. To count or not to count? A review of the issue of adequacy of breast FNA. A Abati, Diag Cytopathol 1999 21 142 147 10.1002/(SICI)1097-0339(199908)21: 2<142::AID-DC123.0.CO;2-Z
38. Should specimen adequacy be determined by the opinion of the aspirator or by the cells on the slides. N Sneige, Cancer Cytopathology 1997 81 3 5 9100533
39. Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens. CS Abendroth HH Wang BS Ducatman, Am J Clin Pathol 1991 96 5 654 9 1659182
40. A plea for uniform terminology and reporting of breast fine needle aspirates. M.D. Anderson Cancer Center proposal. N Sneige GA Staerkel NP Caraway TV Fanning RL Katz, Acta Cytol 1994 38 6 971 2 7992590
41. Interactive Neural network-assisted screening: A clinical assessment. LJ Mango PW Radensky, Acta Cytol 1998 42 233 245 9479346
42. Evaluation of the PAPNET system for prescreening triage of cervicovaginal smears. ? R Ashfaq F Sailger B Solares S Thomas G Liu Y Liang MH Saboorian, Acta Cytol 1997 41 1058 1064 9250299
43. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET testing system. DL Rosenthal D Acosta RK Peters, Acta Cytol 1996 40 120 126 8604564
44. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC system used routinely. B Fetterman G Pawlick H Koo J Hartinger C Gilbert S Connell, Acta Ctol 1999 43 13 22
45. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended use study with routine manual practice. DC Wilbur MU Prey WM Miller GF Pawlick TJ Colgan, Acta Cytol 1998 42 214 220 9479343
46. Sensitivity of the AutoPap 300 QC system for cervical cytologic abnormalities. Biopsy data cofirmation. DC Wilbur TA Bonfiglio MA Rutkowski KM Atkison RM Richart JS Lee SF Patten, Acta Cytol 1996 40 127 132 8604565
47. Dysplasia classification: pathology in disgrace? FT Bosman, J Pathol 2001 194 2 143 4 10.1002/1096-9896(200106)194:2<143::AID-PATH8833.0.CO;2-Z 11400140
48. Cytohistologic discrepancies: a means to improve pathology practice and patient outcomes. KM Clary JF Silverman Y Liu CD Sturgis DM Grzybicki LK Mahood SS Raab, Am J Clin Pathol 2002 117 4 567 73 10.1309/J6JM-2741-HM34-1F1E 11939731
49. Interobserver variation in histopathological grading of cervical dysplasia. HC de Vet PG Knipschild HJ Schouten J Koudstaal WS Kwee D Willebrand F Sturmans JW Arends, J Clin Epidemiol 1990 43 12 1395 8 10.1016/0895-4356(90) 90107-Z 2254777
50. Histologic grading of breast carcinoma. A reproducibility study. LW Dalton DL Page WD Dupont, Cancer 1994 73 11 2765 70 10.1002/1097-0142(19940601) 73:11<2765::AID-CNCR28207311193.0.CO;2-K 8194018
51. Reproducibility of Bayesian belief network assessment of breast fine needle aspirates. WF Whimster PW Hamilton NA Anderson S Humphreys M Boyle M Sundaresan A Rainey A Giles D Hopster PH Bartels, Anal Quant Cytol Histol 1996 18 4 267 74 8862667
52. Expert system support using Bayesian belief networks in the diagnosis of fine needle aspiration biopsy specimens of the breast. PW Hamilton N Anderson PH Bartels D Thompson, J Clin Pathol 1994 47 4 329 36 8027370
53. Application of the learning vector quantizer to the classification of breast lesions. C Markopoulos P Karakitsos E Botsoli-Stergiou A Pouliakis A Ioakim-Liossi K Kyrkou J Gogas, Anal Quant Cytol Histol 1997 19 5 453 60 9349906
54. Potential of the back propagation neural network in the morphologic examination of thyroid lesions. P Karakitsos B Cochand-Priollet PJ Guillausseau A Pouliakis, Anal Quant Cytol Histol 1996 18 6 494 500 8978873
55. Potential of radial basis function neural networks in discriminating benign from malignant lesions of the lower urinary tract. P Karakitsos A Pouliakis G Kordalis J Georgoulakis C Kittas A Kyroudes, Anal Quant Cytol Histol 2005 27 1 35 42 15794450
56. Potential of the back propagation neural network in the discrimination of benign from malignant gastric cells. P Karakitsos EB Stergiou A Pouliakis M Tzivras A Archimandritis AI Liossi K Kyrkou, Anal Quant Cytol Histol 1996 18 3 245 50 8790840
57. Phraseology in pathology reports: a comparative study of interpretation among pathologists and surgeons. RL Attanoos AD Bull AG Douglas-Jones LJ Fligelstone D Semararo, J Clin Pathol 1996 49 79 81 8666692
58. Molecular diagnostic cytopathology: definitions, scope and clinical utility. M Salto-Tellez ES Koay, Cytopathology 2004 15 5 252 5 10.1111/j.1365-2303.2004.00195.x 15456412
59. First CytoJournal Peer-Reviewer's Retreat in 2006 Open access, peer-review, and impact factor. VB Shidham L Sandweiss BF Atkinson, CytoJournal 2006 3 5 doi:10.1186/1742-6413-3-5 16566816 10.1186/1742-6413-3-5
60. Profiling quality of care: Is there a role for peer review? TP Hofer SM Asch RA Hayward LV Rubenstein MM Hogan J Adams EA Kerr, BMC Health Serv Res 2004 19;4 1 9 10.1186/1472-6963-4-9
61. http://www.cytojournal.com/home
62. CytoJournal joins 'open access' philosophy. Shidham B Vinod Anthony Atkinson F Barbara Cafaro, CytoJournal 2004 1 1 (29 July 2004) 15500701 10.1186/1742-6413-1-1
63. How to read a paper: papers that report diagnostic or screening tests. T Greenhalgh, Br Med J 1997 315 540 543
64. Assessing quality of a diagnostic test evaluation. CD Mulrow WD Linn MK Gaul JA Pugh, J Gen Intern Med 1989 4 288 295 2760697
65. Users' guides to the medical literature. III. How to use an article about a diagnostic tests. A. Are the results of the study valid? Evidence-Based Medicine Working Group. R Jaeschke G Guyatt DL Sackett, JAMA 1994 271 389 391 10.1001/jama.271.5.389 8283589
66. Publication bias in clinical research. PJ Easterbrook JA Berline R Gopalan DR Matthews, Lancet 1991 337 867 872 10.1016/0140-6736(91)90201-Y 1672966
67. Changing trends in breast fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Survey. SO Tabbara AR Frost MH Stoler N Sneige MK Sidawy, Diagn Cytopathol 2000 22 2 126 30 10.1002/(SICI)1097- 0339(200002)22:2<126::AID-DC153.0.CO;2-O 10649527
68. Evidence-based Laboratory Medicine: Supporting Decision-Making. CP Price, Clinical Chemistry 2000 46 1041 1050 10926881
69. Validation of a decision support system for the cytodiagnosis of fine needle aspirates of the breast using a prospectively collected dataset from multiple observers in a working clinical environment. SS Cross TJ Stephenson T Mohammed RF Harrisont, Cytopathology 2000 11 6 503 12 10.1046/j.1365-2303.2000. 00290.x 11194082
70. Fine-needle aspiration of the thyroid: an overview. G-K Nguyen MW Lee J Ginsberg T Wragg DB ilodeau, CytoJournal 2005 2 12 doi:10.1186/1742-6413-2-12 15987502 10.1186/1742-6413-2-12
71. The Anal Pap Smear: Cytomorphology of squamous intraepithelial lesions. S Arain AE Walts P Thomas S Bose, Cytojournal 2005 16;2 1 4 10.1186/1742-6413-2-4
72. Combined applications of fine needle aspiration cytology and Flow cytometric immunphenotyping for diagnosis and classification of non Hodgkin Lymphoma. P Dey T Amir A Al Jassar S Al Shemmari S Jogai MG Bhat A Al Quallaf Z Al Shammari, Cytojournal 2006 27;3 24 10.1186/1742-6413-3-24
73. Malignant atypical cell in urine cytology: a diagnostic dilemma. A Bhatia P Dey N Kakkar R Srinivasan R Nijhawan, Cytojournal 2006 15;3 1 28 10.1186/1742-6413-3-28
74. Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma. A Wee, CytoJournal 2005 8;2 7 10.1186/1742-6413-2-7
75. The need for an outcomes research agenda for clinical laboratory testing. GD Lundberg, JAMA 1998 280 565 566 10.1001/jama.280.6.565 9707151